Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/BILAXTEN 12 MG/ML SOLUCIÓN INYECTABLE

Approved

STANDARD

BILAXTEN 12 MG/ML SOLUCIÓN INYECTABLE

Faes Farma S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 30, 2025
Approval ID: 9317e934b39f9871
Company: Faes Farma S.A.
Type: Standard

Approval Details

Approval Id: 9317e934b39f9871
Drug Cima Aemps Name: BILAXTEN 12 MG/ML SOLUCIÓN INYECTABLE
Register Number: 90725
Holder Company Name: Faes Farma S.A.
Marketing Company Name: Faes Farma S.A.
Holder Company Detail Path: /organization/faes-farma-s-a
Marketing Company Detail Path: /organization/faes-farma-s-a
Authorization Date: 2025-10-30
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 12 mg/ml
Route Of Administration: VÍA INTRAMUSCULAR, VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Faes Farma S.A.
Company Detail Path: /organization/faes-farma-s-a

Company Information

Pharmaceutical Company Name: Faes Farma S.A.
Country Name: Chile
City Name: santiago,santiago,country_cl
Address: Isidora Goyenechea 3120 8-A

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 30, 2025

Approval ID

9317e934b39f9871

Type

Standard

Back to CIMA-AEMPS Approvals

BILAXTEN 12 MG/ML SOLUCIÓN INYECTABLE - CIMA-AEMPS Drug Approval Details